Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optical-Coherence Tomography for the Non-invasive Diagnosis and Subtyping of Basal Cell Carcinoma

NCT05041777 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT05041777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05041777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optical-Coherence Tomography for the Non-invasive Diagnosis and Subtyping of Basal Cell Carcinoma
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
February 15, 2017
Completion date
December 30, 2021
Enrollment
963 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence, basal cell carcinoma, deep learning, optical coherence tomography